Interestingly, the week 2 increases observed in AST, ALT, and cholesterol resolved to baseline by 6 weeks post-infection and remained similar to those parameters in the SIV-naïve cohort for the remainder of the study (Figure 4D, Supplementary Table S1). The gene discussed is GPT; the disease is infection.